U.S. market Closed. Opens in 11 hours 41 minutes

ADMA | ADMA Biologics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312014-03-312013-12-312012-12-312011-06-302010-06-302009-06-302008-06-302007-06-30
Revenue258.21M154.08M80.94M42.22M29.35M16.99M22.76M10.66M7.18M5.92MN/A3.07M1.12MN/AN/AN/AN/AN/A
Cost of Revenue170.00M118.81M79.77M61.29M39.50M42.19M29.16M6.36M4.31M3.74MN/A2.02M669.06KN/AN/AN/AN/AN/A
Gross Profit88.22M35.27M1.17M-19.07M-10.16M-25.21M-6.40M4.30M2.87M2.17MN/A1.04M449.06KN/AN/AN/AN/AN/A
Operating Expenses66.59M74.63M59.55M45.84M31.27M35.08M32.06M21.63M18.38M22.00M22.00M16.09M8.36M26.46K20.53KN/A24.92M29.73M
Selling, General & Admin63.29M52.46M42.90M35.05M25.91M22.50M18.09M8.49M6.75M4.82MN/A4.37M3.14M26.46K20.53KN/AN/AN/A
Research & Development3.30M3.61M3.65M5.91M2.34M3.93M6.23M7.69M7.02M9.52MN/A9.30M3.47MN/AN/AN/AN/AN/A
Other Operating Expenses-287.00K18.56M13.00M4.89M3.01M-127.12K7.74M5.45M4.62M7.66M22.00M2.42M1.75MN/AN/AN/A24.92M29.73M
Operating Income21.63M-39.37M-58.37M-64.91M-41.42M-60.29M-39.31M-17.33M-15.51M-16.02MN/A-15.04M-7.91M-26.46K-20.53K-20.01M-24.89M-29.69M
Other Expenses / Income-49.87M-26.54M-13.27M-10.83M-6.85M-127.12K-2.07M-2.18M-2.46M-1.35MN/A-484.81K-9.76K4.004.00N/AN/AN/A
Before Tax Income-28.24M-65.90M-71.65M-75.75M-48.28M-65.74M-43.76M-19.52M-17.97M-17.36MN/A-15.53M-7.92M-26.46K-20.53K-20.01M-24.89M-29.69M
Income Tax Expenses8.16M19.28M12.81M11.86M8.77M5.45MN/AN/AN/A-551.72KN/AN/A-617.62KN/AN/AN/AN/AN/A
Net Income-28.24M-85.18M-84.45M-87.61M-57.05M-65.74M-43.76M-19.52M-17.97M-16.81MN/A-15.53M-7.30M-26.46K-20.53K-20.01M-24.89M-29.69M
Interest Expenses25.03M19.28M13.06M11.99M8.99M5.52M3.29M2.24M1.84M1.29MN/A618.23K30.68KN/AN/AN/AN/AN/A
Basic Shares Outstanding223.98M197.87M139.58M86.15M54.35M45.19M22.90M12.15M10.41M9.29M73.78M6.53M4.65M2.50M2.50M2.50M2.50M2.50M
Diluted Shares Outstanding223.98M197.87M139.58M86.15M54.35M45.19M22.90M12.15M10.41M9.29M9.29M6.53M4.65M2.50M2.50M2.50M2.50M2.50M
EBITDA29.96M-39.24M-57.88M-64.04M-40.01M-56.77M-37.78M-16.81M-15.66M-15.83MN/A-14.70M-7.71M-26.46K-20.53K-20.01M-24.89M-29.69M
EBITDA Margin11.60%-25.47%-71.50%-151.68%-136.31%-334.26%-165.99%-157.64%-218.14%-267.61%0.00%-479.15%-689.21%0.00%0.00%0.00%0.00%0.00%
EBIT4.95M-46.62M-58.59M-63.76M-39.29M-54.77M-40.47M-17.28M-16.13M-16.08MN/A-14.91M-7.89M-26.46K-20.53K-20.01M-24.89M-29.69M
EBIT Margin1.92%-30.26%-72.39%-151.03%-133.86%-322.43%-177.82%-162.04%-224.69%-271.80%0.00%-486.02%-705.49%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312014-03-312013-12-312012-12-312011-06-302010-06-302009-06-302008-06-302007-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙